𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲
◒ 𝑃𝑎𝑡𝑖𝑒𝑛𝑡 𝑆𝑎𝑓𝑒𝑡𝑦 | 𝐷𝑎𝑡𝑎 𝐼𝑛𝑡𝑒𝑔𝑟𝑖𝑡𝑦 ◒
🗣: Wee-See-Ahn
𝗕𝗼𝗿𝗻 𝗮𝗻𝗱 𝗿𝗮𝗶𝘀𝗲𝗱 𝗶𝗻 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲 🇸🇬
𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲:
🏢 Contract Research Organization
📚 ICH GCP E6 (R2)
🏥 Site Feasibility
📂 Regulatory Start-up🇸🇬
🔬 Clinical Monitoring
💊 Pharmacovigilance
🌎 Real World Data
📝 Pharmaceutical Translation
𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗔𝗿𝗲𝗮𝘀:
🦀 Oncology
❤️ Cardiology
🩸 Haematology
🦠 Infectious Diseases
𝗣𝗮𝗿𝗮𝗱𝗶𝗴𝗺𝘀:
⭐️ Decentralized Trials
⚠️ Risk-based Monitoring
💁♀️ Patient-centricity
👩🏻👩🏼Diversity in Clinical Research👩🏽👩🏾
𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗘𝘅𝗽:
Phase 1️⃣
Phase 2️⃣
Phase 3️⃣
💿 𝗦𝗼𝗳𝘁𝘄𝗮𝗿𝗲 𝗖𝗼𝗺𝗽𝗲𝘁𝗲𝗻𝗰𝗶𝗲𝘀:
Clinical Trials Management System
Electronic Data Capture
Computer-assisted Translation
𝗟𝗮𝗻𝗴𝘂𝗮𝗴𝗲𝘀:
🇺🇸 English (EN-US/UK) 🇬🇧 )
🇯🇵 Japanese 日本語 (JA)
======================================
ウィーシアンを申しまして、シンガポール生まれ育ち、臨床開発モニターを研修しております
🧬 臨床研究 | 治験 | 製薬 | バイオテック | CRO | CRA | 薬事申請 | PV | 血液学 | 伝染病 | 癌領域 | 循環器 | 呼吸器 | 根拠に基づく医療 | 医薬翻訳🧬
🔮 座右の銘
「愚者は経験に学び、賢者は歴史に学ぶ」〜血鉄宰相ビスマルク
↔️ 𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝗺𝗲 𝘃𝗶𝗮 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻: http://linkedin.com/in/weesianglim
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
September 08, 2023 | 169 | +2 | +1.2% |
October 27, 2022 | 167 | +2 | +1.3% |
August 24, 2022 | 165 | +1 | +0.7% |
June 11, 2022 | 164 | -6 | -3.6% |
May 04, 2022 | 170 | +2 | +1.2% |
March 27, 2022 | 168 | +1 | +0.6% |
January 28, 2022 | 167 | +3 | +1.9% |
December 22, 2021 | 164 | +6 | +3.8% |
November 13, 2021 | 158 | -1 | -0.7% |
October 06, 2021 | 159 | +6 | +4.0% |